PCOM Forms Research Partnership with CansortiumSeptember 7, 2018
PCOM, already approved as a certified Academic Clinical Research Center under Pennsylvania's
Medical Marijuana law, will re-apply under new regulations.
Cansortium Health Partners, a Cansortium Holdings subsidiary, will apply as a Clinical
Registrant, entrusted with producing and dispensing medical marijuana products.
Cansortium Holdings, LLC, is dedicated to compassionately provide patients access
to the highest quality medicinal marijuana in an unrivaled, professional healthcare
environment that puts the welfare of patients first.
Philadelphia College of Osteopathic Medicine (PCOM) and Cansortium Holdings, LLC (Cansortium) have announced the formation of a partnership
to conduct significant medical marijuana research in Pennsylvania. PCOM will seek
to be re-certified as an Academic Clinical Research Center in Pennsylvania under new
regulations and Cansortium will apply for a Clinical Registrant license.
This partnership represents a new research collaboration dedicated to generating knowledge
that further defines marijuana’s therapeutic applications. Both organizations bring
unique qualifications to the partnership. As one of Pennsylvania’s largest medical
colleges, PCOM is widely regarded for its advancements in medical research and the education it provides to the next generation of physicians and healthcare professionals. Cansortium, a
global medical marijuana company serving thousands of patients throughout the US and
Latin America, has demonstrated industry-leading innovations in cultivation, extraction,
medical formulation and in-house testing.
“Through the forethought and vision of Governor Wolf and the state legislature in
creating the ACRC program, Pennsylvania is poised to become a national and international
leader in medical cannabis research. We at PCOM are committed to helping lead the
way with a best-in-class partner in Cansortium,” commented Jay Feldstein, DO '81, president and CEO of PCOM.
Under Pennsylvania's medical marijuana laws, the partners are permitted to conduct
extensive research on the pharmacology, biochemistry and long-term best practices
for patients on medical marijuana regimens. PCOM's team of investigators has developed
a collaborative, interdisciplinary research program that will examine the impact of
medical marijuana on physical and mental health, quality of life, chronic pain and
opioid utilization and addiction. Results of these studies will be shared among researchers
to accelerate the pace of evidence-based recommendations of medical marijuana for
the treatment of specific conditions.
“After a rigorous selection process, it is an honor and privilege for Cansortium to
partner with a leading medical research institution that aligns with our holistic
approach to patient care,” said Jose Hidalgo, Cansortium Founder & CEO. “At the end
of the day, our company is focused on outcomes that improve the lives of our patients
suffering from debilitating diseases and disorders. It is our expectation that the
data and insights emerging from this partnership will greatly expand the US-based
scientific documentation around the many benefits of medical marijuana.”
Participants will be recruited on a statistically sound basis for voluntary longitudinal
studies across multiple conditions and disciplines. To support these efforts, Cansortium
as the clinical registrant is permitted to open up to six retail dispensaries across
the state to coordinate research efforts and dispense product directly to patients.
Those facilities also play a vital role as hubs for physician education and outreach
You May Also Like:
For questions for PCOM and interview requests with Mindy George-Weinstein, chief science
and research officer, please email Renee Cree at firstname.lastname@example.org
For questions for Cansortium and interview requests with Jose Hidalgo, please email
Scott Klenet at email@example.com.
About Cansortium Holdings, LLC
Cansortium Holdings, LLC, seeks to redefine excellence in medical marijuana with operations
in the US, Canada, and other markets around the world. Cansortium is committed to
compassionately provide patients access to the highest quality medicinal marijuana
in an unrivaled, professional healthcare environment. Cansortium, through its brand
Knox Medical, earned a license to dispense medical marijuana in York County, PA in
2017. One dispensary located in Hanover, PA opened earlier this year and has experienced
robust sales growth as new product offerings come onto the market.
About Philadelphia College of Osteopathic Medicine
Founded in 1899, Philadelphia College of Osteopathic Medicine (PCOM) has trained thousands
of highly competent, caring physicians, health practitioners and behavioral scientists
who practice a “whole person” approach to care—treating people, not just symptoms.
PCOM operates three campuses (PCOM, PCOM Georgia and PCOM South Georgia) and offers doctoral degrees in clinical psychology, educational psychology, osteopathic
medicine, pharmacy, physical therapy and school psychology, and graduate degrees in
applied behavior analysis, applied positive psychology, biomedical sciences, forensic
medicine, medical laboratory science, mental health counseling, non profit leadership
and population health management, organizational development and leadership, physician
assistant studies, school psychology, and public health management and administration.
PCOM students learn the importance of health promotion, research, education and service
to the community. Through its community-based Healthcare Centers, PCOM provides care
to medically underserved populations. For more information, visit pcom.edu or call 215-871-6100.
For more information, contact:
Associate Director, News and Media Relations
Office: 215-871-6304 | Cell:
Connect with PCOM